The Valley Desk

NCT04136353 · Interventional trial

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Overall registry status Active not recruiting

Phase 3

Conditions Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov